Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 10/20 | 0.47 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PAK4 | O96013 | 2/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29967082 | 0.79 | GAA (0.49) | HSD11B1HPGDMEN1KMT2ADPP4 | |
| SCHEMBL29967247 | 0.79 | GAA (0.49) | HSD11B1HPGDMEN1KMT2ADPP4 | |
| Hydrochloric Acid SCHEMBL3714221 | 0.78 | HPGD (0.48) | HSD11B1HPGDMEN1KMT2ADPP4 | |
| SCHEMBL31568105 | 0.77 | RXFP1 (0.63) | P2RX7HSD11B1HPGDNPC1MEN1 | |
| SCHEMBL30671638 | 0.77 | SMN1; SMN2 (0.49) | HSD11B1HPGDALDH1A1DPP4 | |
| SCHEMBL30671642 | 0.76 | DPP4 (0.55) | HSD11B1MEN1ALDH1A1KMT2ADPP4 | |
| Hydrochloric Acid SCHEMBL3715997 | 0.76 | SMN1; SMN2 (0.48) | HSD11B1HPGDALDH1A1KMT2ADPP4 | |
| Hydrochloric Acid SCHEMBL3712824 | 0.75 | DPP4 (0.54) | HSD11B1MEN1ALDH1A1KMT2ADPP4 | |
| SCHEMBL30691934 | 0.73 | P2RX7 (0.54) | P2RX7HSD11B1HPGDNPC1MEN1 | |
| SCHEMBL31454276 | 0.73 | P2RX7 (0.54) | P2RX7HSD11B1HPGDNPC1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022096-A1 | NOVEL SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS | GENECODE (EE) | 2026-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022096-A1 | NOVEL SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS | CNR1, CDR2, SMN1; SMN2 | P2RX7 3218/4885HSD11B1 589/4885HPGD 2805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.